These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
75 related articles for article (PubMed ID: 20625354)
1. Visceral Kaposi's sarcoma remission after intestinal transplant. First case report and systematic literature review. D'Amico F; Fuxman C; Nachman F; Bitetti L; Fauda M; Echevarria C; Solar H; Politi P; Cabanne A; Mauriño E; Ruf A; Gondolesi GE Transplantation; 2010 Sep; 90(5):547-54. PubMed ID: 20625354 [TBL] [Abstract][Full Text] [Related]
2. [Successful treatment with liposomal doxorubicin and foscarnet in a patient with widespread Kaposi's sarcoma and human herpes virus 8-related, serious hemophagocytic syndrome, after renal transplantation]. Bossini N; Sandrini S; Setti G; Luppi M; Maiorca P; Maffei C; Cancarini G G Ital Nefrol; 2005; 22(3):281-6. PubMed ID: 16001371 [TBL] [Abstract][Full Text] [Related]
3. Complete regression of visceral Kaposi's sarcoma after conversion to sirolimus. Mohsin N; Budruddin M; Pakkyara A; Darweesh A; Nayyer M; Amitabh J; Daar AS Exp Clin Transplant; 2005 Dec; 3(2):366-9. PubMed ID: 16417445 [TBL] [Abstract][Full Text] [Related]
4. Sirolimus for Kaposi's sarcoma in renal-transplant recipients. Stallone G; Schena A; Infante B; Di Paolo S; Loverre A; Maggio G; Ranieri E; Gesualdo L; Schena FP; Grandaliano G N Engl J Med; 2005 Mar; 352(13):1317-23. PubMed ID: 15800227 [TBL] [Abstract][Full Text] [Related]
5. A novel immunosuppressive agent, sirolimus, in the treatment of Kaposi's sarcoma in a renal transplant recipient. Yilmaz R; Akoglu H; Kirkpantur A; Kilickap S; Arici M; Altun B; Aki T; Erdem Y; Yasavul U; Turgan C Ren Fail; 2007; 29(1):103-5. PubMed ID: 17365918 [TBL] [Abstract][Full Text] [Related]
6. Molecularly targeted therapy for Kaposi's sarcoma in a kidney transplant patient: case report, "what worked and what did not". Volkow P; Zinser JW; Correa-Rotter R BMC Nephrol; 2007 Mar; 8():6. PubMed ID: 17386117 [TBL] [Abstract][Full Text] [Related]
7. Regression of Kaposi's sarcoma in renal graft recipients after conversion to sirolimus treatment. Zmonarski SC; Boratyńska M; Rabczyński J; Kazimierczak K; Klinger M Transplant Proc; 2005 Mar; 37(2):964-6. PubMed ID: 15848592 [TBL] [Abstract][Full Text] [Related]
8. Kaposi's sarcoma resolves after sirolimus therapy in a patient with pemphigus vulgaris. Saggar S; Zeichner JA; Brown TT; Phelps RG; Cohen SR Arch Dermatol; 2008 May; 144(5):654-7. PubMed ID: 18490593 [TBL] [Abstract][Full Text] [Related]
10. Kaposi sarcoma in solid organ transplant recipients: a single center report. Boeckle E; Boesmueller C; Wiesmayr S; Mark W; Rieger M; Tabarelli D; Graziadei I; Hoefer D; Antretter H; Stelzmueller I; Krugmann J; Zangerle R; Huemer H; Poelzl G; Margreiter R; Bonatti H Transplant Proc; 2005 May; 37(4):1905-9. PubMed ID: 15919500 [TBL] [Abstract][Full Text] [Related]
11. Successful treatment of a child having generalized Kaposi's sarcoma after living donor liver transplantation with conversion to sirolimus. Yuksekkaya HA; Arikan C; Yazici A; Baran M; Aydogdu S; Kilic M Pediatr Transplant; 2009 May; 13(3):375-8. PubMed ID: 18452496 [TBL] [Abstract][Full Text] [Related]
12. Successful treatment of post-renal transplant gastric and pulmonary Kaposi's sarcoma with conversion to rapamycin treatment. Charfi S; Krichen-Makni S; Yaich S; Makni H; Khabir A; Amouri A; Charfeddine K; Hachicha J; Sellami-Boudawara T Saudi J Kidney Dis Transpl; 2007 Nov; 18(4):617-20. PubMed ID: 17951954 [TBL] [Abstract][Full Text] [Related]
14. Sirolimus-induced signaling modifications in Kaposi's sarcoma with resolution in a liver transplant recipient. Ho CM; Huang SF; Hu RH; Ho MC; Wu YM; Lee PH Clin Transplant; 2010; 24(1):127-32. PubMed ID: 19919613 [TBL] [Abstract][Full Text] [Related]
17. Kaposi's sarcoma in renal transplant patients: predisposing factors and prognosis. Berber I; Altaca G; Aydin C; Dural A; Kara VM; Yigit B; Turkmen A; Titiz MI Transplant Proc; 2005 Mar; 37(2):967-8. PubMed ID: 15848593 [TBL] [Abstract][Full Text] [Related]
18. Treatment of HIV-1-associated Kaposi's sarcoma with pegylated liposomal doxorubicin and HAART simultaneously induces effective tumor remission and CD4+ T cell recovery. Lichterfeld M; Qurishi N; Hoffmann C; Hochdorfer B; Brockmeyer NH; Arasteh K; Mauss S; Rockstroh JK; Infection; 2005 Jun; 33(3):140-7. PubMed ID: 15940415 [TBL] [Abstract][Full Text] [Related]
19. Population pharmacokinetics and pharmacodynamics of pegylated-liposomal doxorubicin in patients with AIDS-related Kaposi's sarcoma. Amantea MA; Forrest A; Northfelt DW; Mamelok R Clin Pharmacol Ther; 1997 Mar; 61(3):301-11. PubMed ID: 9084455 [TBL] [Abstract][Full Text] [Related]
20. Kaposi's sarcoma in association with Behcet's disease: case report and literature review. Mezalek ZT; Harmouche H; Attar NE; Serraj K; Aouni M; Adnaoui M; Maaouni A Semin Arthritis Rheum; 2007 Apr; 36(5):328-31. PubMed ID: 17240427 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]